PharmiWeb.com - Global Pharma News & Resources
23-Feb-2021

Global C-reactive protein testing market size to reach US$ 1.9 Billion by 2025 at a CAGR of 2.2%

Noida, Uttar Pradesh, India, February 23 2021 (Wiredrelease) Report Ocean Pvt Ltd –:Global C-Reactive Protein Testing Market is estimated to see healthy growth, pegged at a CAGR of ~2.2% during the forecast period 2020-2025. The primary factors influencing the growth of the C-reactive protein testing market include the rise in prevalence of inflammatory disorders, the increasing global incidence of endometriosis in women, the rise in funding toward the technological advancement in diagnostics, and the rise in the adoption of point-of-care devices.

Click Here To Access Free Sample Report @ https://www.reportocean.com/industry-verticals/sample-request?report_id=bis48149

Several technical studies have shown the C-reactive proteins role as an inflammatory marker in gastrointestinal illnesses. This has also accelerated the reliance on these proteins to diagnose a disease such as acute pancreatitis and Crohn’s disease. The initiatives undertaken by government agencies to increase awareness and uptake of point-of-care are factors driving the market.

The rising prevalence of gastrointestinal diseases coupled with subsequent demand for robust disease testing protocols has driven the market to a considerable extent. POC-based CRP testing within healthcare settings and among patients drives the market growth. For instance, the NICE (National Institute for Health and Care Excellence) has recommended the POC CRP testing usage in primary care for adult patients diagnosed with respiratory tract infections.

Increase in investments for research entities engaged in performing research activities in this area boosts market progression. The National Institute for Health Research, the Wellcome Trust, and the Department for International Development are among the few funding agencies supporting C-reactive protein tests related research activities.

C-Reactive Protein Testing Market: Key Trends

Initiatives by government bodies to promote point-of-care (POC) testing in healthcare settings boost the C-reactive protein testing market. In recent years, point-of-care testing methods have gained immense popularity as these tests provide rapid and accurate results in minimal time.

Besides, the development of novel techniques for analyzing the concentration of C-reactive protein opens new avenues for the C-reactive protein testing market’s growth. For example, a study carried out in November 2019 involved developing a movable smartphone-based diffusometric immunoassay for finding C-reactive protein concentration.

Segmentation Overview of the Global C-reactive protein testing Market

The C-reactive protein testing market is segmented based on Device Type, Diameter Size, and Material. These major market segments are further categorized into various sub-segments to study the market in detail.

By Assay Type Outlook

Immunoturbidimetric Assay
ELISA (Clinical, Nonclinical)
Chemiluminescence Immunoassay
Others

By Detection Range Outlook (hs-CRP, Conventional CRP, cCRP)

By Disease Area Outlook (Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, Others)

By End-Use Outlook
Clinics
By Entity (Physician Offices, Small Clinics, Others)
By Settings (Urban Setting, Rural Setting)
Hospitals (Urban Setting, Rural Setting)
Laboratories (Urban Setting, Rural Setting)
Assisted Living Healthcare Facilities (Urban Setting, Rural Setting)
Home
Others

Key Players Insights

MicroVention, Inc. (Terumo Corp.), Medtronic, BALT Extrusion SA, Penumbra Inc., Stryker Corporation, Phenox GmbH, MicroPort Scientific Corporation, and Acandis, among others, are some significant players included in the research study of the global C-reactive protein testing market. Leading companies in the C-reactive protein testing market make significant investments to expand their product offerings and improve its globalmarket position. Keen players are also involved in collaborations and partnerships with research bodies to expand the uptake of point-of-care C-reactive protein testing. 

For Purchase Enquiry: @ https://www.reportocean.com/industry-verticals/sample-request?report_id=bis48149

This content has been published by Report Ocean Pvt Ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at contact@wiredrelease.com.

Editor Details

Last Updated: 23-Feb-2021